Efficacy of rosiglitazone and pioglitazone compared to other anti-diabetic agents
Subtitle: systematic review and budget impact analysis
By: Michel Boucher ... [et al.].
Contributors: Boucher, Michel, B Pharm.; Canadian Coordinating Office for Health Technology Assessment.
Series: Technology report -- issue 29; Technology report (Canadian Coordinating Office for Health Technology Assessment) -- issue 29.
Publisher: Canadian Coordinating Office for Health Technology Assessment
Published: 2002
Place of publication: Ottawa
Language: eng
Number of pages: 76
Subjects: Diabetes -- Chemotherapy.; Hypoglycemic agents.; Cost effectiveness.; Diabetes Mellitus -- drug therapy.; Hypoglycemic Agents -- therapeutic use.; Cost-Benefit Analysis.
Notes: "October 2002."

Includes bibliographical references (p. 52-57).